Double-blind clinical evaluation of mazindol (42-548) in obese diabetics.
D001835:Body Weight; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003975:Diazepam / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D008454:Mazindol / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009765:Obesity; D010919:Placebos; D012885:Skinfold Thickness; D013997:Time Factors
D007211:Indoles; D010919:Placebos; D008454:Mazindol; D003975:Diazepam